The alternate pathway of complement activation. The role of C3 and its inactivator (KAF).
- 1 February 1973
- journal article
- Vol. 24 (2) , 259-75
Abstract
The immunochemical depletion from serum of C3b inactivator (KAF) has been performed using purified F(ab′)2 antibody. In vitro KAF depletion leads to spontaneous activation of the `alternate pathway of complement fixation' as evidenced by conversion of glycine-rich β-glycoprotein, depletion of cobra venom factor—C3 proactivator and conversion of C3.This publication has 29 references indexed in Scilit:
- C3 LEUKOTACTIC FACTORS PRODUCED BY A TISSUE PROTEASEThe Journal of Experimental Medicine, 1969
- ISOLATION OF A FRAGMENT (C3a) OF THE THIRD COMPONENT OF HUMAN COMPLEMENT CONTAINING ANAPHYLATOXIN AND CHEMOTACTIC ACTIVITY AND DESCRIPTION OF AN ANAPHYLATOXIN INACTIVATOR OF HUMAN SERUMThe Journal of Experimental Medicine, 1969
- C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.1969
- The Demonstration in Human Serum of “Conglutinogen-Activating Factor” and its Effect on the Third Component of ComplementThe Journal of Immunology, 1968
- Studies of the In Vivo Behavior of Human C′3 in Normal Subjects and Patients*Journal of Clinical Investigation, 1967
- Three Naturally-Occurring Inhibitors of Components of Complement in Guinea Pig and Rabbit SerumThe Journal of Immunology, 1967
- A PLASMIN-SPLIT FRAGMENT OF C'3 AS A NEW CHEMOTACTIC FACTORThe Journal of Experimental Medicine, 1967
- A new concept of immunosuppression in hypersensitivity reactions and in transplantation immunity.1966
- ANTIGENIC DETERMINANTS OF HUMAN BETA1C- AND BETA1G-GLOBULINS1966
- PREPARATION AND PROPERTIES OF ALEXINATED INTERMEDIATES THAT REACT WITH CONGLUTININ .I. GUINEA-PIG COMPLEMENT1966